MTOR and nasopharyngeal carcinoma: Herein, we performed this study, which enrolled 496 NPC patients treated by IMRT with or without chemotherapy, aimed to identify the potential associations between genetic variations in PI3K/PTEN/AKT/mTOR pathway and the occurrence of distant metastasis in patients with NPC.